Community/Retail

Pharmacists can educate patients on controlling risk factors and stay up-to-date on emerging therapies like SGLT2 inhibitors and finerenone that can slow disease progression.

Lp(a) is a critical risk factor for atherosclerotic cardiovascular disease, but current lipid-lowering therapies are largely ineffective at lowering Lp(a) levels.

Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.

Some outsourcers and pharmacies have capitalized on the shortages, producing compounded versions.

The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.

Adding HIV/AIDS to core chronic diseases is a key change.

The disparity highlights opportunities for pharmacists to get involved and address health disparities.

Plaintiff argues that "blacklisting” certain individuals with opioid prescriptions was unlawful.

Pharmacists are crucial in educating patients, identifying eligible individuals, and promoting uptake of the newly expanded RSV vaccination recommendations for older adults.

Study results show that the updated BNT162b2 XBB vaccine is effective in preventing hospitalizations or emergency department visits associated with COVID-19 complications.

Muvalaplin is an oral, small molecule inhibitor that can reduce lipoprotein(a).

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

Federal legislation would seek to foster development of antibiotics.

High levels of the Oscillibacter genus of bacteria were associated with reduced cholesterol.

Adoption barriers include insurance coverage, patient and provider education, and regulatory hurdles that require aligned initiatives across stakeholders.

Proper reporting of errors and near misses helps maintain compliance and improve patient safety.

Researchers recommend early vaccination against herpes zoster to mitigate the risks.

Pharmacists can significantly improve chronic obstructive pulmonary disease (COPD) management by promoting non-pharmacological interventions.

The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.

Patient education on the risks of the long-term illness can help overcome vaccine hesitancy.

Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.

Short-term spinal cord stimulation could provide long-term pain relief and improve the overall quality of life for individuals with herpes zoster-associated pain and postherpetic neuralgia.

The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.

The 2025 GOLD Report emphasizes the importance of tailoring combination treatments based on patient factors like eosinophil counts and exacerbation history.

The nasal spray label resembles that of the FDA-approved epinephrine injection, leading to potential dosing errors.

Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.

Pharmacists are essential in preventing the significant health and economic burden of respiratory syncytial virus (RSV) infections in older adults through vaccination.

Providing crucial information allows patients to take charge of their treatments.